Chronic kidney disease perspectives in Japan and the importance of urinalysis screening

[1]  R. Chisin.  Cost-Effectiveness Analysis , 2009, Journal of Nuclear Medicine.

[2]  Katherine M. Steckler Rn,et al.  End-Stage Renal Disease , 2008 .

[3]  A. Levey,et al.  Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  R. Elston,et al.  Genome-Wide Scans for Diabetic Nephropathy and Albuminuria in Multiethnic Populations , 2007, Diabetes.

[5]  B. Brenner,et al.  Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. , 2007, Journal of the American Society of Nephrology : JASN.

[6]  T. Sairenchi,et al.  Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. , 2007, Kidney international.

[7]  S. Nakai.  An overview of dialysis treatment in Japan (as of Dec. 31, 2005) , 2007 .

[8]  Racial differences in trends of end-stage renal disease, by primary diagnosis--United States, 1994-2004. , 2007, MMWR. Morbidity and mortality weekly report.

[9]  Chun-Yuh Yang,et al.  Epidemiological features of CKD in Taiwan. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  G. Eknoyan,et al.  Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2006, Kidney international.

[11]  M. Tonelli,et al.  Differences in use of peritoneal dialysis and survival among East Asian, Indo Asian, and white ESRD patients in Canada. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  F. Dekker,et al.  Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey , 2006, BMJ : British Medical Journal.

[13]  J. Wetzels,et al.  Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. , 2006, Journal of the American Society of Nephrology : JASN.

[14]  I. Kubota,et al.  Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. , 2006, Kidney international.

[15]  N. Powe,et al.  International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. , 2006, Journal of the American Society of Nephrology : JASN.

[16]  R Nair,et al.  Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? , 2006, Kidney international.

[17]  F. Irie,et al.  The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. , 2006, Kidney international.

[18]  P. Roderick,et al.  Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  G. Remuzzi,et al.  Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. , 2006, The Journal of clinical investigation.

[20]  A. Collins,et al.  Projecting the number of patients with end-stage renal disease in the United States to the year 2015. , 2005, Journal of the American Society of Nephrology : JASN.

[21]  Giuseppe Remuzzi,et al.  Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. , 2005, Kidney international. Supplement.

[22]  M. Kubo,et al.  Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. , 2005, Kidney international.

[23]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[24]  M. Murakami,et al.  Proteinuria screening for children. , 2005, Kidney international. Supplement.

[25]  G. Remuzzi,et al.  Albuminuria as early test for vascular disease , 2005, The Lancet.

[26]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[27]  B. Brenner,et al.  From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. , 2004, Kidney international.

[28]  Raymond Vanholder,et al.  The burden of kidney disease: improving global outcomes. , 2004, Kidney international.

[29]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[30]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[31]  B. Brenner,et al.  Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy , 2004, Circulation.

[32]  Zhongxin Zhang,et al.  Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.

[33]  Deeb N Salem,et al.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.

[34]  Hideto Takahashi,et al.  Age distribution and yearly changes in the incidence of ESRD in Japan. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  N. Day,et al.  Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. , 2004, International journal of epidemiology.

[36]  N. Powe,et al.  Screening for proteinuria in US adults: a cost-effectiveness analysis. , 2003, JAMA.

[37]  Kiyoshi Kurokawa,et al.  Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. , 2003, Kidney international.

[38]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[39]  G. Mayer,et al.  Regional variability in the incidence of end-stage renal disease: an epidemiological approach. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  M. Klag,et al.  Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[41]  R. Foley,et al.  End-stage renal disease in Indo-Asians in the North-West of England. , 2003, QJM : monthly journal of the Association of Physicians.

[42]  I. Narita,et al.  The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. , 2003, Kidney international.

[43]  K. Iseki,et al.  Proteinuria and the risk of developing end-stage renal disease. , 2003, Kidney international.

[44]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  A. Garg,et al.  Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. , 2003, Kidney international.

[46]  Hans L Hillege,et al.  Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.

[47]  R. Henning,et al.  Dual renin-angiotensin system blockade at optimal doses for proteinuria. , 2002, Kidney international.

[48]  M. Mariani,et al.  Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[49]  F. Port,et al.  Risk factors for proteinuria in a large, multiracial, southeast Asian population. , 2002, Journal of the American Society of Nephrology : JASN.

[50]  A. Garg,et al.  Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III , 2002 .

[51]  Hideto Takahashi,et al.  Prognosis of Asymptomatic Hematuria and/or Proteinuria in Men , 2002, Nephron.

[52]  M. Mariani,et al.  OR-47: High-normal albuminuria and the risk of cardiovascular and renal complications in hypertensive men , 2002 .

[53]  A. Levey.  K/DOQI practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Part 2. Background , 2002 .

[54]  Lysaght Mj,et al.  Maintenance Dialysis Population Dynamics: Current Trends and Long-Term Implications , 2002 .

[55]  Michael J Lysaght,et al.  Maintenance dialysis population dynamics: current trends and long-term implications. , 2002, Journal of the American Society of Nephrology : JASN.

[56]  S. Adler,et al.  Clinical and demographic predictors of exercise capacity in end-stage renal disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[57]  D. Cattran,et al.  Predicting progression in IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  Y. Taguma,et al.  Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[59]  T. Sairenchi,et al.  Factors affecting renal function in 119 985 adults over three years. , 2001, QJM : monthly journal of the Association of Physicians.

[60]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[61]  C. Schmid,et al.  Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. , 2001, Kidney international.

[62]  M. Nagata,et al.  Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features. , 2001, Internal medicine.

[63]  R. Hughes,et al.  Rare Cause of Cardiomyopathy , 2001 .

[64]  Jing Liu,et al.  Sino-MONICA Project: A Collaborative Study on Trends and Determinants in Cardiovascular Diseases in China, Part I: Morbidity and Mortality Monitoring , 2001, Circulation.

[65]  T A Louis,et al.  Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. , 2001, Journal of the American Society of Nephrology : JASN.

[66]  W. Keane.  Proteinuria: its clinical importance and role in progressive renal disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[67]  M. Hori,et al.  Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[68]  E. Jones,et al.  Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[69]  F. Locatelli,et al.  Corticosteroids in IgA nephropathy: a randomised controlled trial , 1999, The Lancet.

[70]  M. Pfeffer,et al.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[71]  A. Levey.  Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[72]  Masaki Kobayashi,et al.  Natural history and risk factors for immunoglobulin a nephropathy in Japan , 1997 .

[73]  K. Yamagata,et al.  A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. , 1996, Clinical nephrology.

[74]  K. Iseki,et al.  Risk of developing end-stage renal disease in a cohort of mass screening. , 1996, Kidney international.

[75]  J. Feehally,et al.  High incidence of end-stage renal disease in Indo-Asians in the UK. , 1995, QJM : monthly journal of the Association of Physicians.

[76]  C. Charasse,et al.  Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. , 1994, Kidney international.

[77]  M. McCredie,et al.  Trends in incidence of end-stage renal failure in Australia, 1972-1991. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[78]  J. Feehally,et al.  Increased Incidence of End‐stage Renal Failure Secondary to Diabetes Mellitus in Asian Ethnic Groups in the United Kingdom , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[79]  J. Cameron,et al.  Proteinuria and progression in human glomerular diseases. , 1990, American journal of nephrology.

[80]  D. Himmelstein,et al.  Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. II. Bacteriuria , 1990, JAMA.

[81]  S Woolhandler,et al.  Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. , 1989, JAMA.

[82]  G. D'Amico,et al.  The commonest glomerulonephritis in the world: IgA nephropathy. , 1987, The Quarterly journal of medicine.

[83]  P. J. Van Breda Vriesman,et al.  Epidemiology of idiopathic glomerular disease: a prospective study. , 1987, Kidney international.